UN health R&D summit 'leaves the greater part of the job undone.' MSF's Statement at the close of the UN Health R&D Summit

GAVI and the AMC Will governments make the right decision on May 20th ?

Food Crisis Campaign director highlights children's special nutritional needs to the BBC

Malnutrition As global food shortages bite, MSF warns donors not to miss the target with food aid that fails children

Home

Other Diseases

: © Juan Carlos Tomasi

MSF has been working since 1999 with patients suffering from Chagas. This parasitical disease, found on the American continent, affects around 16 - 18 million people. New drugs and diagnostics are needed to tackle the disease, including medications adapted for children.

Click here for a slide show on Chagas

MSF and Neglected Diseases

Slideshow of Kala Azar Treatment in Bihar, India

: © MSF

In Bihar, India, Doctors Without Borders/Médecins Sans Frontières (MSF) treats people living amid the world's highest concentration of visceral leishmaniasis, also known as kala azar.

Click here to see slideshow

Sleeping Sickness Fact Sheet

: © Juan Carlos Tomasi

60 million people are at risk of contracting sleeping sickness, or human African trypanosomiasis (HAT). The disease affects 36 countries across sub-Saharan Africa. Nearly eliminated in the 1960s, the disease has been making a massive comeback due to war, population movements and the collapse of health systems.

Click here to read MSF's Fact Sheet on Sleeping Sickness

DNDi launches new malaria treatment

Co-founder of the Drugs for Neglected Diseases Initiative, MSF has been pushing for new models of medical innovation, allowing for the development of better more affordable drugs that target the diseases of the poor.

Last year DNDi launched their first product, a patent free combination therapy for malaria, AS/AQ.

MSF's press release

About AS/AQ